High Intensity Focussed Ultrasound (HIFU) uses focused ultrasound waves to destroy pathological tissue by rapid heating. The efficacy of such treatments is well proven; they are less invasive and outcomes are often much better than surgery.
MR-HIFU utilises high quality MR imaging to plan, deliver and monitor non invasive ultrasound therapy. The new MR-HIFU system will allow clinicians to:
Currently MRgHIFU is CE marked for treatment of uterine fibroids and palliation of pain from bone metastases. Our goal is to expand the scope of indications for MRgHIFU, beyond these, to include other musculo-skeletal conditions, breast cancer, primary renal tumours, neurolysis and targeted drug delivery.